Welcome!
The AGLYC project is about developing a new IVD test based on the quantification of specific protein modifications as a novel and disruptive approach to detect cardiac ischemia.
THE AGLYC PROJECT
The project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 826930 (Phase I) and No. 849047 (Phase II).
100
%
Production of AGLYC Reagents
60
%
Clinical Validation of AGLYC
60
%
Business Relevant Activities IP Protection
70
%
Regulatory Quality Management
55
%
Communication and Dissemination
66
%
Project Management
A GlyCardial Diagnostics’ Project
Latest News
Be the first to read
GlyCardial Diagnostics completes recruitment in the EDICA trial
GlyCardial Diagnostics has completed patient recruitment in EDICA trial: a multicenter international clinical study for the early detection of Myocardial Ischaemia.
© Copyright 2019. All rights reserved